Amiloride Hydrochloride/Furosemide

盐酸阿米洛利/呋塞米

Report date: 2025/08/21 17:51:31

Base Information

Drug NameAmiloride Hydrochloride/Furosemide

Drug Alias Name复方呋塞米

ClassificationSmall molecules

Mechanisms of ActionSodium channel alpha subunit blockersSodium-(potassium)-chloride cotransporter 2 inhibitorsGamma-aminobutyric acid A receptor antagonists

TargetsSodium channel alpha subunitSodium-(potassium)-chloride cotransporter 2Gamma-aminobutyric acid A receptor

Therapy Area/IndicationsEdemaEdema, Cardiac

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsYes Amiloride Hydrochloride Furosemide

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesN/A

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsEdemaEdema, Cardiac

Inactive IndicationsN/A

Other Information

ATC CodeN/A